Yahoo Search Búsqueda en la Web

Resultado de búsqueda

  1. Hace 2 días · At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. That’s why for more than 135 years, we have aimed to keep people well at every age and every stage of life.

  2. Hace 2 días · NEW BRUNSWICK, NJ (May 28, 2024) – Johnson & Johnson (NYSE: JNJ) announced today it has entered into a definitive agreement with Numab Therapeutics, a clinical-stage biotechnology company advancing a pipeline of immunology and oncology therapeutics, to acquire from Numab’s shareholders its wholly-owned subsidiary for the global rights to a novel, investigational first-in-class bispecific ...

  3. Hace 1 día · May 28, 2024 at 5:46 AM PDT. Listen. 1:27. Johnson & Johnson agreed to pay $1.25 billion for the rights to an experimental eczema treatment, the latest big pharma deal for a new type of drug that ...

  4. Hace 1 día · Johnson & Johnson (J&J) sigue ampliando su cartera de medicamentos innovadores con la adquisición de Yellow Jersey Therapeutics por 1.250 millones de dólares. Este movimiento estratégico le otorga a J&J un medicamento experimental prometedor para el tratamiento del eccema, denominado NM26, que se encuentra listo para entrar en las pruebas de Fase 2 en dermatitis atópica, una forma común ...

  5. Hace 1 día · Johnson & Johnson on Tuesday agreed to acquire the rights to an experimental skin disorder treatment from privately held Numab Therapeutics for about $1.25 billion, its second deal for an eczema ...

  6. 2022 Health for Humanity Report. Explore past issues of the Health for Humanity Report dating back to 2017. The print and digital publications we produce each year that recap the company’s business performance and key enterprise-wide milestones.

  7. 3 de may. de 2024 · La conocida empresa de productos para bebés presentó una oferta para resolver las querellas civiles contra su talco, acusado de contener amianto y causar cáncer de ovario. J&J confía en que el...